271 related articles for article (PubMed ID: 32125790)
1. The expression landscape of cachexia-inducing factors in human cancers.
Freire PP; Fernandez GJ; de Moraes D; Cury SS; Dal Pai-Silva M; Dos Reis PP; Rogatto SR; Carvalho RF
J Cachexia Sarcopenia Muscle; 2020 Aug; 11(4):947-961. PubMed ID: 32125790
[TBL] [Abstract][Full Text] [Related]
2. Tumour-derived transforming growth factor-β signalling contributes to fibrosis in patients with cancer cachexia.
Lima JDCC; Simoes E; de Castro G; Morais MRPT; de Matos-Neto EM; Alves MJ; Pinto NI; Figueredo RG; Zorn TMT; Felipe-Silva AS; Tokeshi F; Otoch JP; Alcantara P; Cabral FJ; Ferro ES; Laviano A; Seelaender M
J Cachexia Sarcopenia Muscle; 2019 Oct; 10(5):1045-1059. PubMed ID: 31273954
[TBL] [Abstract][Full Text] [Related]
3. Association of circulating PLA2G7 levels with cancer cachexia and assessment of darapladib as a therapy.
Morigny P; Kaltenecker D; Zuber J; Machado J; Mehr L; Tsokanos FF; Kuzi H; Hermann CD; Voelkl M; Monogarov G; Springfeld C; Laurent V; Engelmann B; Friess H; Zörnig I; Krüger A; Krijgsveld J; Prokopchuk O; Fisker Schmidt S; Rohm M; Herzig S; Berriel Diaz M
J Cachexia Sarcopenia Muscle; 2021 Oct; 12(5):1333-1351. PubMed ID: 34427055
[TBL] [Abstract][Full Text] [Related]
4. Comprehensive Characterization of Cachexia-Inducing Factors in Diffuse Large B-Cell Lymphoma Reveals a Molecular Subtype and a Prognosis-Related Signature.
Kuang Z; Li X; Liu R; Chen S; Tu J
Front Cell Dev Biol; 2021; 9():648856. PubMed ID: 34079795
[TBL] [Abstract][Full Text] [Related]
5. Generation and initial characterization of novel tumour organoid models to study human pancreatic cancer-induced cachexia.
Vaes RDW; van Dijk DPJ; Welbers TTJ; Blok MJ; Aberle MR; Heij L; Boj SF; Olde Damink SWM; Rensen SS
J Cachexia Sarcopenia Muscle; 2020 Dec; 11(6):1509-1524. PubMed ID: 33047901
[TBL] [Abstract][Full Text] [Related]
6. C/EBPβ promotes the expression of atrophy-inducing factors by tumours and is a central regulator of cancer cachexia.
AlSudais H; Rajgara R; Saleh A; Wiper-Bergeron N
J Cachexia Sarcopenia Muscle; 2022 Feb; 13(1):743-757. PubMed ID: 35014202
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of epidermal growth factor receptor suppresses parathyroid hormone-related protein expression in tumours and ameliorates cancer-associated cachexia.
Weber BZC; Agca S; Domaniku A; Bilgic SN; Arabaci DH; Kir S
J Cachexia Sarcopenia Muscle; 2022 Jun; 13(3):1582-1594. PubMed ID: 35373517
[TBL] [Abstract][Full Text] [Related]
8. Expression of the proteolysis-inducing factor core peptide mRNA is upregulated in both tumour and adjacent normal tissue in gastro-oesophageal malignancy.
Deans DA; Wigmore SJ; Gilmour H; Tisdale MJ; Fearon KC; Ross JA
Br J Cancer; 2006 Mar; 94(5):731-6. PubMed ID: 16495932
[TBL] [Abstract][Full Text] [Related]
9. Tumour-derived leukaemia inhibitory factor is a major driver of cancer cachexia and morbidity in C26 tumour-bearing mice.
Kandarian SC; Nosacka RL; Delitto AE; Judge AR; Judge SM; Ganey JD; Moreira JD; Jackman RW
J Cachexia Sarcopenia Muscle; 2018 Dec; 9(6):1109-1120. PubMed ID: 30270531
[TBL] [Abstract][Full Text] [Related]
10. Cancer cachexia induces morphological and inflammatory changes in the intestinal mucosa.
Costa RGF; Caro PL; de Matos-Neto EM; Lima JDCC; Radloff K; Alves MJ; Camargo RG; Pessoa AFM; Simoes E; Gama P; Cara DC; da Silva ASF; O Pereira W; Maximiano LF; de Alcântara PSM; Otoch JP; Trinchieri G; Laviano A; Muscaritoli M; Seelaender M
J Cachexia Sarcopenia Muscle; 2019 Oct; 10(5):1116-1127. PubMed ID: 31307125
[TBL] [Abstract][Full Text] [Related]
11. High levels of modified ceramides are a defining feature of murine and human cancer cachexia.
Morigny P; Zuber J; Haid M; Kaltenecker D; Riols F; Lima JDC; Simoes E; Otoch JP; Schmidt SF; Herzig S; Adamski J; Seelaender M; Berriel Diaz M; Rohm M
J Cachexia Sarcopenia Muscle; 2020 Dec; 11(6):1459-1475. PubMed ID: 33090732
[TBL] [Abstract][Full Text] [Related]
12. Lipopolysaccharide-induced hypothalamic inflammation in cancer cachexia-anorexia is amplified by tumour-derived prostaglandin E2.
Li X; Holtrop T; Jansen FAC; Olson B; Levasseur P; Zhu X; Poland M; Schalwijk W; Witkamp RF; Marks DL; van Norren K
J Cachexia Sarcopenia Muscle; 2022 Dec; 13(6):3014-3027. PubMed ID: 36303458
[TBL] [Abstract][Full Text] [Related]
13. Clinical impact of cachexia on survival and outcome of cancer patients.
Dimitriu C; Martignoni ME; Bachmann J; Fröhlich B; Tintărescu G; Buliga T; Lică I; Constantinescu G; Beuran M; Friess H
Rom J Intern Med; 2005; 43(3-4):173-85. PubMed ID: 16812978
[TBL] [Abstract][Full Text] [Related]
14. Tumor-Derived Sarcopenia Factors Are Diverse in Different Tumor Types: A Pan-Cancer Analysis.
Gan X; Zeng Y; Huang J; Chen X; Kang H; Huang S
Biomedicines; 2024 Jan; 12(2):. PubMed ID: 38397931
[TBL] [Abstract][Full Text] [Related]
15. Distinct cachexia profiles in response to human pancreatic tumours in mouse limb and respiratory muscle.
Nosacka RL; Delitto AE; Delitto D; Patel R; Judge SM; Trevino JG; Judge AR
J Cachexia Sarcopenia Muscle; 2020 Jun; 11(3):820-837. PubMed ID: 32039571
[TBL] [Abstract][Full Text] [Related]
16. Pancreatic cancer induces muscle wasting by promoting the release of pancreatic adenocarcinoma upregulated factor.
Yoo W; Choi H; Son YH; Lee J; Jo S; Jung D; Kim YJ; Koh SS; Yang YR; Kwon ES; Lee KP; Noh KH; Kim KW; Ko Y; Jun E; Kim SC; Kim S
Exp Mol Med; 2021 Mar; 53(3):432-445. PubMed ID: 33731895
[TBL] [Abstract][Full Text] [Related]
17. Gut microbiota and short-chain fatty acid alterations in cachectic cancer patients.
Ubachs J; Ziemons J; Soons Z; Aarnoutse R; van Dijk DPJ; Penders J; van Helvoort A; Smidt ML; Kruitwagen RFPM; Baade-Corpelijn L; Olde Damink SWM; Rensen SS
J Cachexia Sarcopenia Muscle; 2021 Dec; 12(6):2007-2021. PubMed ID: 34609073
[TBL] [Abstract][Full Text] [Related]
18. Pathophysiology of cancer cachexia: much more than host-tumour interaction?
Skipworth RJ; Stewart GD; Dejong CH; Preston T; Fearon KC
Clin Nutr; 2007 Dec; 26(6):667-76. PubMed ID: 17507116
[TBL] [Abstract][Full Text] [Related]
19. Targeting RAGE prevents muscle wasting and prolongs survival in cancer cachexia.
Chiappalupi S; Sorci G; Vukasinovic A; Salvadori L; Sagheddu R; Coletti D; Renga G; Romani L; Donato R; Riuzzi F
J Cachexia Sarcopenia Muscle; 2020 Aug; 11(4):929-946. PubMed ID: 32159297
[TBL] [Abstract][Full Text] [Related]
20. Brain metabolites in cholinergic and glutamatergic pathways are altered by pancreatic cancer cachexia.
Winnard PT; Bharti SK; Sharma RK; Krishnamachary B; Mironchik Y; Penet MF; Goggins MG; Maitra A; Kamel I; Horton KM; Jacobs MA; Bhujwalla ZM
J Cachexia Sarcopenia Muscle; 2020 Dec; 11(6):1487-1500. PubMed ID: 33006443
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
